Clinical Trial Update: Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tadalafil in combination with chemotherapy for resectable gastric or gastroesophageal junction adenocarcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: University of Arizona | Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: RECRUITING